GlassScriptPhysician profile
Vishwanatha Nadig
NPI 1740266998
$8,828.23
in general payments reported to CMS, 2019-2025
23 companies · $7,700 in 2025
The $7,700 reported for 2025 was more than what 87% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.21 · 2020: $60.57 · 2021: $239 · 2023: $28.88 · 2024: $758 · 2025: $7,700.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,935 · Food and Beverage: $2,552.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,934.71 |
| Food and Beverage | $2,551.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,762.51 | 2023-2025 | Sensia, Micra, Advisa Dr Mri Surescan |
| Philips North America LLC | $1,529.80 | 2024-2025 | Igt Devices Undivided, (5153) Azurion 5 M20 Gc, IV Other |
| Edwards Lifesciences Corporation | $1,197.60 | 2024-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Biotronik INC. | $280.63 | 2019-2025 | Acticor 7 Vr-T Dx |
| Scpharmaceuticals INC. | $120.16 | 2024-2025 | |
| Ge Healthcare | $119.27 | 2024 | |
| Angiodynamics, INC. | $112.79 | 2024 | Auryon Laser System 100-120 Vac |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $109.02 | 2021-2025 | Lifevest |
| Abbott Laboratories | $68.44 | 2021-2025 | Assurity |
| E.R. Squibb & Sons, L.L.C. | $64.75 | 2021-2025 | Camzyos |
| Shockwave Medical, INC | $63.80 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $56.64 | 2024-2025 | Jardiance |
| Amgen INC. | $49.26 | 2025 | Repatha |
| Astrazeneca Pharmaceuticals LP | $45.67 | 2025 | Farxiga |
| Bridgebio Pharma, INC. | $41.81 | 2025 | Attruby |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $37.77 | 2025 | |
| Pfizer INC. | $37.10 | 2025 | |
| Cleerly, INC. | $34.76 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Terumo Medical Corporation | $20.86 | 2025 | Glidewire, Metacross Otw |
| Ethicon US, LLC | $19.79 | 2025 | Vistaseal, Stratafix |
| Abiomed | $19.74 | 2025 | |
| Boston Scientific Corporation | $18.62 | 2021 | |
| Novo Nordisk INC | $17.44 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vishwanatha Nadig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.